logo
episode-header-image
Oct 2023
50m 50s

America Goes Psychedelic, Again

The Center For Investigative Reporting And Prx
About this episode

Psychedelic drugs have been illegal for 50 years, but they’re trickling back into the mainstream because they show promise in helping treat post-traumatic stress disorder and other mental health challenges.

We begin the hour with reporter Jonathan A. Davis visiting Psychedelic Science 2023, the largest-ever conference on psychedelic drugs. It’s put on by the Multidisciplinary Association for Psychedelic Studies, an organization dedicated to legalizing MDMA (also known as ecstasy or molly) and other psychedelic drugs. Research shows that MDMA-assisted therapy can help treat depression and PTSD, and it’s moving toward approval by the U.S. Food and Drug Administration. Psychedelics were studied in the 1950s and ’60s as mental health treatments, but the war on drugs put a stop to research. Now, these drugs are gaining bipartisan support from politicians looking for solutions to the mental health crisis among veterans. 

Then Reveal’s Michael I Schiller visits a group of veterans who are not waiting for psychedelic-assisted therapy to be approved by the federal government. They’ve joined a church founded by an Iraq War veteran who uses psychedelics as religious sacraments. Schiller accompanies them on a retreat in rural Texas, where they share the depths of their post-traumatic stress and the relief they’ve felt after psychedelic treatments. He also explores the risks involved in taking these drugs. 

We close with an intimate audio diary from a woman in Oakland, California, who’s going through therapy with the one psychedelic drug that can be legally prescribed currently in the U.S.: ketamine. Ketamine started out as an anesthetic, but researchers found it can help with treatment-resistant depression when used in tandem with talk therapy. Ketamine can be dangerous if abused, but it also has helped people find relief from mental health issues. This story was produced by Davis.

Up next
Jul 5
A Decade of Reveal
This week on Reveal, we celebrate our 10-year anniversary with a look back at some of our favorite stories, from investigations into water shortages in drought-prone California to labor abuses in the Dominican Republic. And we interview the journalists behind the reporting to exp ... Show More
50m 39s
Jul 2
Jeffrey Goldberg on Signalgate, Pete Hegseth, and the Risk of WWIII
In March, The Atlantic’s editor-in-chief, Jeffrey Goldberg, began receiving top secret messages from national security officials in the Trump administration after he’d been inadvertently added to an internal Signal chat. Many of those same officials oversaw recent military strike ... Show More
30m 24s
Jun 28
Elon Musk and JD Vance Want You to Breed. A Lot.
What do Silicon Valley billionaires, religious parents of six, and eugenics-curious biotech founders have in common? Welcome to the world of pronatalism—a growing movement that aims to solve the so-called population crisis by making more babies.We follow the unlikely alliance bet ... Show More
50m 30s
Recommended Episodes
May 2024
The Power and Promise of Psychedelics in Therapy
Bad trips, anti-drug PSAs, and the crackdown under the Controlled Substances Act of 1970 helped stigmatize psychedelics in the U.S. But now, there’s renewed clinical inquiry into whether these drugs can ease emotional trauma. To understand the future of psychedelics, Audie calls ... Show More
37m 39s
Sep 2022
Babbage: How psychedelics could fix the brain
Psychedelic drugs—such as LSD and psilocybin, the psychoactive compound found in magic mushrooms—may be coming to the medicine cabinet. Research into their use to treat mental-health conditions was long blocked by law and stigma. But in recent years, there has been a revival of i ... Show More
44m 25s
Sep 2022
Babbage: How psychedelics could fix the brain
Psychedelic drugs—such as LSD and psilocybin, the psychoactive compound found in magic mushrooms—may be coming to the medicine cabinet. Research into their use to treat mental-health conditions was long blocked by law and stigma. But in recent years, there has been a revival of i ... Show More
44m 25s
Jan 2023
What Promise Do Psychedelics Hold As Therapeutics?
When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for de ... Show More
34m 17s
Apr 2021
Lucas Richert, "Break on Through: Radical Psychiatry and the American Counterculture" (MIT Press, 2020)
"Antipsychiatry," Esalen, psychedelics, and DSM III: Radical challenges to psychiatry and the conventional treatment of mental health in the 1970s. The upheavals of the 1960s gave way to a decade of disruptions in the 1970s, and among the rattled fixtures of American society was ... Show More
47m 4s
Nov 2022
What Promise Do Psychedelics Hold As Therapeutics?
When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for de ... Show More
33m 13s
Jun 2020
17. Veterans & Psychedelics part 3 – From Shock to Awe with Mitch Schultz
From an early age, Mitch Schultz's curiosity of the unknown universe forged his path in storytelling. His work as a transmedia producer, UX designer, and educator explores the inherent connections among consciousness, nature, culture, and the evolving human mythology.The Document ... Show More
32m 30s
Nov 2020
How psychedelic drugs are being used to help mental health and the terminally ill
This week in the U.S. Electoral vote, in Washington, D.C., and Oregon, voters chose to get on the path to decriminalize psilocybin for therapeutic use. This past August in Canada, four terminally ill cancer patients were given approval to use psilocybin as part of their end of li ... Show More
22m 25s
Jul 2023
Professor David Nutt
Psychedelics have been stigmatised and criminalised for over 50 years, but David Nutt, a professor of neuropsychopharmacology and a leading worldwide authority on drugs, feels we’re on the cusp of a major revolution in psychiatric medicine and neuroscience that could see psychede ... Show More
48m 9s